Trial Profile
Effect of integrase inhibitor (MK-0518) on decay of low level viral replication in HIV reservoirs in infected individuals who initiated conventional antiretroviral therapy during the chronic phase of infection
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Raltegravir (Primary) ; Antiretrovirals
- Indications HIV-1 infections
- Focus Therapeutic Use
- 14 Nov 2011 Status changed from not yet recruiting to completed, results have been fully published in AIDS.
- 31 Aug 2007 New trial record.